Inhibikase Therapeutics (IKT) Debt Ratio (2020 - 2025)
Inhibikase Therapeutics (IKT) posted quarterly Debt Ratio of 0.0 for Q2 2025, down 97.52% year-over-year from 0.02 in Q2 2024, and down 46.15% quarter-over-quarter from 0.0 in Q1 2025.
Inhibikase Therapeutics (IKT) Debt Ratio (2020 - 2025) Analysis & Trends
Inhibikase Therapeutics (IKT) has reported Debt Ratio for 6 consecutive years, with 0.0 the latest figure, recorded in Q2 2025.
- In Q2 2025, Debt Ratio fell 97.52% year-over-year to 0.0; the TTM figure through Jun 2025 stood at 0.0 (down 97.52% YoY), while the FY2024 annual figure was 0.0, down 96.94% from the prior year.
- Debt Ratio eased to 0.0 in Q2 2025 per IKT's latest filing, from 0.0 in the prior quarter.
- Across five years, Debt Ratio topped out at 0.1 in Q1 2021 and bottomed at 0.0 in Q2 2025.
- Historically, Debt Ratio has averaged 0.02 across 5 years, with a median of 0.01 in 2022.
- Annual changes were most pronounced in 2023 — Debt Ratio soared 526.92% — and 2025, when it slumped 97.52%.
- Inhibikase Therapeutics' Debt Ratio stood at 0.01 in 2021, then grew by 7.77% to 0.01 in 2022, then jumped by 526.92% to 0.04 in 2023, then tumbled by 96.94% to 0.0 in 2024, then tumbled by 61.9% to 0.0 in 2025.
- Business Quant data shows IKT's Debt Ratio at 0.0 in Q2 2025, 0.0 in Q1 2025, and 0.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 0.05 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 0.12 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.47 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 0.26 |
| 10 | Inhibikase Therapeutics | 420.72 Mn | 261.70 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 0.00 |
| Mar 31, 2025 | 0.00 |
| Dec 31, 2024 | 0.00 |
| Sep 30, 2024 | 0.03 |
| Jun 30, 2024 | 0.02 |
| Mar 31, 2024 | 0.01 |
| Dec 31, 2023 | 0.04 |
| Sep 30, 2023 | 0.01 |
| Jun 30, 2023 | 0.01 |
| Mar 31, 2023 | 0.01 |
| Dec 31, 2022 | 0.01 |
| Sep 30, 2022 | 0.00 |
| Sep 30, 2021 | 0.01 |
| Jun 30, 2021 | 0.01 |
| Mar 31, 2021 | 0.10 |
| Dec 31, 2020 | 0.02 |